HDR UK Gateway
HDR Gateway logo

Bookmarks

IMPORT-HIGH - A phase III randomised trial testing dose-escalated simultaneous integrated boost radi

Population Size

Not reported
Population Size statistic card

Years

2023

Years statistic card

Associated BioSamples

Availability to be confirmed

Associated BioSamples statistic card

Geographic coverage

United Kingdom

Geographic coverage statistic card

Lead time

Other

Lead time statistic card

Summary

Clinical data and blood samples from the IMPORT HIGH trial

Documentation

IMPORT HIGH is a phase 3, non-inferiority, open-label, randomised controlled trial that recruited women after breast-conserving surgery for pT1–3pN0–3aM0 invasive carcinoma from radiotherapy and referral centres in the UK. Clinical data and blood samples are available.

Dataset type

Health and disease

Provenance

Purpose of dataset collection

Trial

Source of data extraction

Other

Collection source setting

Cohort, study, trial

Image contrast

Not stated

Biological sample availability

Availability to be confirmed

Details

Publishing frequency

Static

Version

1.0.0

Modified

07/01/2026

Coverage

Start date

24/06/2023

Time lag

Not applicable

Geographic coverage

United Kingdom

Minimum age range

23

Maximum age range

87

Follow-up

1 - 10 Years

Accessibility

Language

en

Alignment with standardised data models

LOCAL

Controlled vocabulary

LOCAL

Format

In Progress

Data Access Request

Dataset pipeline status

Not available

Access rights

Please contact the publisher using Contact Point details provided

Time to dataset access

Other

Access request cost

Not specified

Jurisdiction

UK

Data Controller

The Institute of Cancer Research

Data Processor

The Institute of Cancer Research

Dataset Types: Health and disease

Dataset Sub-types: Cancer

Collection Sources: Cohort, study, trial